Our results suggest that alleles for Braf and other members of the ERK/MAPK pathway may represent risk factors for the development of psychiatric diseases, either by copy number variations in affected genotypes [58] or by altered epigenetic control of gene expression. This evidence concerns the gene BRAF and psychiatric disorder.